Market Place
Sourcing Support
Opthea’s Wet AMD Program to be Featured at FLORetina 2024
26 Nov 2024 //
GLOBENEWSWIRE
Opthea to Participate in Citi 2024 Global Healthcare Conference
25 Nov 2024 //
GLOBENEWSWIRE
Opthea Appoints Kathy Connell to Board of Directors
15 Nov 2024 //
GLOBENEWSWIRE
Opthea’s Wet AMD Program Featured at Ophthalmology Events
12 Nov 2024 //
GLOBENEWSWIRE
Opthea to Participate in November Investor Conferences
04 Nov 2024 //
GLOBENEWSWIRE
Opthea Files Notice of Annual General Meeting
16 Oct 2024 //
GLOBENEWSWIRE
Opthea Wet AMD Program to be Presented at Innovate Retina
10 Oct 2024 //
GLOBENEWSWIRE
Opthea Appoints Chief Medical Officer And Chief Financial Officer
08 Oct 2024 //
GLOBENEWSWIRE
Opthea to Participate in the UBS Virtual Ophthalmology Day 2024
30 Sep 2024 //
GLOBENEWSWIRE
Opthea Joins the S&P/ASX 300 Index
23 Sep 2024 //
GLOBENEWSWIRE
Opthea To Have Presence At 24th EURETINA Congress
10 Sep 2024 //
GLOBENEWSWIRE
Opthea Announces Executive Leadership Changes and Senior Hires
05 Sep 2024 //
GLOBENEWSWIRE
Opthea to Attend H.C. Wainwright and Cantor Global Healthcare Conferences
03 Sep 2024 //
GLOBENEWSWIRE
Opthea Reports Full-Year Financial Results and Business Updates
30 Aug 2024 //
GLOBENEWSWIRE
Opthea To Participate In H.C. Wainwright Ophthalmology Conference
08 Aug 2024 //
GLOBENEWSWIRE
Opthea Adds Retina Experts To Medical Advisory Board
17 Jul 2024 //
GLOBENEWSWIRE
Opthea Announces Results of the A$55.9m (US$36.9m¹) Retail Entitlement Offer
14 Jul 2024 //
GLOBENEWSWIRE
Opthea Publishes On VEGF-C And D Pathways In Wet AMD Treatment
09 Jul 2024 //
GLOBENEWSWIRE
Opthea A$55.0m (US$36.9m) Retail Entitlement Offer Opens
18 Jun 2024 //
GLOBENEWSWIRE
Opthea Raises A$171.5M Via Placement And Entitlement Offer
13 Jun 2024 //
GLOBENEWSWIRE
Opthea Announces Placement & Partially Underwritten Entitlement Offer to Raise
11 Jun 2024 //
GLOBENEWSWIRE
Opthea To Present at Clinical Trials at the Summit Meeting
03 Jun 2024 //
GLOBENEWSWIRE
Opthea: Enrollment Complete For Sozinibercept Wet AMD Phase 3 Program
28 May 2024 //
GLOBENEWSWIRE
Opthea Announces Upcoming Presentations at the Retina World Congress 2024
01 May 2024 //
GLOBENEWSWIRE
Opthea to Present at the OIS Retina Innovation Summit at ARVO
25 Apr 2024 //
GLOBENEWSWIRE
Opthea Appoints John Han, PharmD, as VP Medical Affairs
08 Apr 2024 //
GLOBENEWSWIRE
Opthea to Participate in the 23?? Annual Needham Virtual Healthcare Conference
04 Apr 2024 //
GLOBENEWSWIRE
Opthea Appoints Sujal Shah to the Board of Directors
03 Apr 2024 //
GLOBENEWSWIRE
Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302)
19 Mar 2024 //
GLOBENEWSWIRE
Opthea to Participate in the Leerink Partners Global Biopharma Conference
05 Mar 2024 //
GLOBENEWSWIRE
Opthea Reports Half-Year Financial Results and Business Updates
28 Feb 2024 //
GLOBENEWSWIRE
Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor
19 Feb 2024 //
GLOBENEWSWIRE
Opthea Completes Enrollment in First Pivotal Trial with Sozinibercept
14 Feb 2024 //
GLOBENEWSWIRE
Opthea Strengthens Team with Key Clinical and Regulatory Hires
01 Feb 2024 //
GLOBENEWSWIRE
Opthea to Receive US$35M Commitment and Additional US$50M Funding
27 Dec 2023 //
GLOBENEWSWIRE
Opthea Receives A$8.8 million R&D Tax Incentive
19 Dec 2023 //
GLOBENEWSWIRE
Opthea to Present at the FLORetina 2023 Congress
01 Dec 2023 //
GLOBENEWSWIRE
Opthea to Present at Eyecelerator Forum at the AAO Conference
30 Oct 2023 //
GLOBENEWSWIRE
Opthea Appoints Leadership with Fred Guerard as CEO and Peter Lang as CFO
27 Oct 2023 //
GLOBENEWSWIRE
Opthea to Participate at the 2023 Euretina Congress
02 Oct 2023 //
GLOBENEWSWIRE
Opthea Announces “Sozinibercept†as the Nonproprietary Drug Name for OPT-302
26 Jul 2023 //
GLOBENEWSWIRE
Opthea to Present at the 2023 Ophthalmology Innovation Summit
24 Jul 2023 //
GLOBENEWSWIRE
Opthea to Feature at American Society of Retina Specialists 2023 Annual Meeting
13 Jul 2023 //
GLOBENEWSWIRE
Opthea Announces Departure of CMO & Appointment of Senior Medical Advisor
10 Jul 2023 //
GLOBENEWSWIRE
Opthea Appoints Anshul Thakral as Non-Executive Director of the Board
08 Jun 2023 //
GLOBENEWSWIRE
Opthea to Present at the Jefferies 2023 Healthcare Conference
25 May 2023 //
GLOBENEWSWIRE
Opthea to Participate in EF Hutton Hosted Discussion on OPT-302
17 May 2023 //
GLOBENEWSWIRE
Opthea To Present at the JMP Securities Life Sciences Conference
08 May 2023 //
GLOBENEWSWIRE
Opthea To Participate at the H.C. Wainwright BioConnect Conference at NASDAQ
28 Apr 2023 //
GLOBENEWSWIRE
Opthea Receives A$8.7 million R&D Tax Incentive
07 Mar 2023 //
GLOBENEWSWIRE
Opthea To Participate in Fireside Chat at Oppenheime`s Conference
06 Mar 2023 //
GLOBENEWSWIRE
Opthea P2b Trial Results of OPT-302 with Lucentis Published in the Journal
13 Feb 2023 //
GLOBENEWSWIRE
Opthea To Present at SVB Leerink Global Biopharma Conference
06 Feb 2023 //
GLOBENEWSWIRE
Opthea To Present at Sequire Biotechnology Conference
30 Jan 2023 //
GLOBENEWSWIRE
Opthea Announce MST Access Hosted Call with Professor Jason S. Slakter, MD
12 Dec 2022 //
GLOBENEWSWIRE
Opthea to Present at Jefferies London Healthcare Conference
10 Nov 2022 //
GLOBENEWSWIRE
Opthea Expands Leadership Team with the Appointment of Timothy E. Morris as CFO
24 Oct 2022 //
GLOBENEWSWIRE
Opthea Announces Presentation at 2nd Annual Ophthalmology Conference
16 Aug 2022 //
GLOBENEWSWIRE
Opthea To Present at Upcoming Investor Conferences
11 May 2022 //
GLOBENEWSWIRE
Opthea Presentation at The Retina World Congress 2022
10 May 2022 //
GLOBENEWSWIRE
